Does UBIDECARENONE Cause Hepatic encephalopathy? 34 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Hepatic encephalopathy have been filed in association with UBIDECARENONE (CO Q 10). This represents 9.4% of all adverse event reports for UBIDECARENONE.
34
Reports of Hepatic encephalopathy with UBIDECARENONE
9.4%
of all UBIDECARENONE reports
0
Deaths
34
Hospitalizations
How Dangerous Is Hepatic encephalopathy From UBIDECARENONE?
Of the 34 reports, 34 (100.0%) required hospitalization.
Is Hepatic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UBIDECARENONE. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does UBIDECARENONE Cause?
Drug ineffective (130)
Headache (125)
Pain (125)
Malaise (115)
Off label use (114)
Nausea (113)
Therapeutic product effect incomplete (113)
Abdominal pain (109)
Constipation (109)
Pyrexia (109)
What Other Drugs Cause Hepatic encephalopathy?
ACETAMINOPHEN (562)
RIBAVIRIN (512)
LENVATINIB (502)
RIFAXIMIN (462)
SOFOSBUVIR (360)
BEVACIZUMAB (210)
LEDIPASVIR\SOFOSBUVIR (180)
ATEZOLIZUMAB (178)
SORAFENIB (169)
DACLATASVIR (165)
Which UBIDECARENONE Alternatives Have Lower Hepatic encephalopathy Risk?
UBIDECARENONE vs UBLITUXIMAB
UBIDECARENONE vs UBLITUXIMAB-XIIY
UBIDECARENONE vs UBROGEPANT
UBIDECARENONE vs ULIPRISTAL
UBIDECARENONE vs UMBRALISIB